Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Subject-blinded, Randomized Study to Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent in Patients Undergoing Drug-eluting Stent Procedure After Coronary Angiography

NCT03089450 is registered in ClinicalTrials.gov with CGBio Inc. as lead sponsor.

NCT NCT03089450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03089450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Subject-blinded, Randomized Study to Evaluate Safety and Efficacy of CGBIO Stent Compared to Biomatrix Flex Stent in Patients Undergoing Drug-eluting Stent Procedure After Coronary Angiography
Lead sponsor
CGBio Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
March 22, 2017
Completion date
June 30, 2018
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease, nstemi - non-st segment elevation mi, stable angina, stable coronary artery disease, unstable angina